Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y 12 Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial-Reference-Cited by-同舟云学术

Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y 12 Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial

Published:2019-03-19 Issue:6 Volume:8 Page:
ISSN:2047-9980
Container-title:Journal of the American Heart Association
language:en
Short-container-title:JAHA

Author:

Franchi Francesco¹,James Stefan K.²³,Ghukasyan Lakic Tatevik³,Budaj Andrzej J.⁴,Cornel Jan H.⁵,Katus Hugo A.⁶,Keltai Matyas⁷,Kontny Frederic⁸,Lewis Basil S.⁹,Storey Robert F.¹⁰,Himmelmann Anders¹¹,Wallentin Lars²³,Angiolillo Dominick J.¹,

Affiliation:

1. University of Florida, College of Medicine‐Jacksonville Jacksonville FL

2. Department of Medical Sciences Cardiology Uppsala University Uppsala Sweden

3. Uppsala Clinical Research Center Uppsala University Uppsala Sweden

4. Postgraduate Medical School Grochowski Hospital Warsaw Poland

5. Department of Cardiology Noordwest Ziekenhuisgroep Alkmaar Netherlands

6. Medizinishe Klinik Universitätsklinikum Heidelberg Heidelberg Germany

7. Hungarian Institute of Cardiology Semmelweis University Budapest Hungary

8. Department of Cardiology Stavanger University Hospital Stavanger Norway

9. Lady Davis Carmel Medical Center Haifa Israel

10. Department of Infection, Immunity and Cardiovascular Disease University of Sheffield United Kingdom

11. AstraZeneca, Research and Development Gothenburg Sweden